The planned purchase of Medivation, with its $2.2 billion-a-year Xtandi, is the latest in a number of deals by large drugmakers willing to pay top dollar for cancer drugs that are more effective than standard, older treatments
Read More
Ajay Piramal-led pharma-to-finance group Piramal Enterprises has signed a definitive agreement to acquire 100%stake of the US-based drug developer and custom manufacturer Ash Stevens Inc for a total consideration of Rs 353.4 crore
Read More
The company reported a lower-than-expected quarterly profit as revenues in its home market were hit by government measures to cut drug prices
Read More
Sun Pharmaceutical Industries reported a quarterly profit that beat analysts' estimates, helped by its exclusive launch of the first generic version of leukaemia drug Gleevec in the United States
Read More
Indian pharmaceutical market regained its growth momentum in July after a weak trajectory in the previous three to four months
Read More
Sales in North America, Lupin's largest market, surged 82.3 per cent, helped by sales of products bought via the acquisition of Gavis in July, and higher sales of its generic version of diabetes drug Glumetza
Read More
Ever larger number of Indians are suffering from infertility, and domestic and foreign players are rushing in to tap the IVF treatment market
Read More
The latest $25 million investment is on the back of fast growing sterile (injections, ophthalmic solutions etc) market in the US
Read More
Sales of generic medicines rose 16 percent to $6.04 billion, helped by Pfizer's $16 billion purchase last year of generic hospital products company Hospira
Read More
Under the terms of this agreement, Kyowa will book the sales of the 21 products after December 1, 2016, and Shionogi will receive 15.4 billion yen from Kyowa
Read More
